CHANDRA MARLIN NP
Prescription History 1881237808
Nurse Practitioner - Family in Columbus, IN
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for CHANDRA MARLIN NP, an active Family specialist practicing in Columbus, IN. Our medical registry currently tracks 18 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,456 documented patient claims. Among these therapy options, the most frequently utilized medication is Tamsulosin Hcl, which accounts for 358 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other IN PrescribersVs. IN Avg |
|---|---|---|---|
| Tamsulosin Hcl | 358 | $22.48 | ▲ More than typical |
About Tamsulosin Hcl: Tamsulosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Tamsulosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. In 2023, this provider wrote 358 Medicare prescriptions for Tamsulosin Hcl, about 3.8 times the volume of the typical Indiana prescriber of this medication (94). Medicare paid an average of $22.48 per fill, versus $20.52 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 859.6 30-Day Fills standardized to 30-day supplies 25,306 Days of Medication total across all patients in 2023 | |||
| MyrbetriqMirabegron | 241 | $619.62 | ▲ More than typical |
About Myrbetriq: This medication is used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Show more ▾ Overactive bladder is a problem with how your bladder stores urine. Neurogenic detrusor overactivity is a bladder control condition caused by brain, spinal cord, or nerve problems. Symptoms of these conditions may include frequent urination, strong sudden urges to urinate that are hard to control, or involuntary loss of urine (incontinence). Mirabegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder and neurogenic detrusor overactivity. In 2023, this provider wrote 241 Medicare prescriptions for Myrbetriq, about 5.4 times the volume of the typical Indiana prescriber of this medication (45). Medicare paid an average of $619.62 per fill, versus $614.85 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 339 30-Day Fills standardized to 30-day supplies 9,714 Days of Medication total across all patients in 2023 | |||
| Finasteride | 154 | $15.17▼ below IN avg | ▲ More than typical |
About Finasteride: Finasteride is used to shrink an enlarged prostate (benign prostatic hyperplasia or BPH) in adult men. Show more ▾ It may be used alone or taken in combination with other medications to reduce symptoms of BPH and may also reduce the need for surgery. Finasteride may improve symptoms of BPH and provide benefits such as decreased urge to urinate, better urine flow with less straining, less of a feeling that the bladder is not completely emptied, and decreased nighttime urination. This medication works by decreasing the amount of a natural body hormone (DHT) that causes growth of the prostate. Finasteride is not approved for prevention of prostate cancer. It may slightly increase the risk of developing a very serious form of prostate cancer. Talk to your doctor about the benefits and risks. Women and children should not use this medication. An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA. In 2023, this provider wrote 154 Medicare prescriptions for Finasteride, about 2.8 times the volume of the typical Indiana prescriber of this medication (56). Medicare paid an average of $15.17 per fill, versus $17.24 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 433.3 30-Day Fills standardized to 30-day supplies 12,989 Days of Medication total across all patients in 2023 | |||
| Estradiol | 112 | $100.90 | ▲ More than typical |
About Estradiol: This medication is a female hormone (estrogen). Show more ▾ It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In 2023, this provider wrote 112 Medicare prescriptions for Estradiol, about 4 times the volume of the typical Indiana prescriber of this medication (28). Medicare paid an average of $100.90 per fill, versus $55.88 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 255.5 30-Day Fills standardized to 30-day supplies 7,631 Days of Medication total across all patients in 2023 | |||
| Solifenacin Succinate | 99 | $88.37 | ▲ More than typical |
About Solifenacin Succinate: Solifenacin is used to treat an overactive bladder. Show more ▾ By relaxing the muscles in the bladder, solifenacin improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. This medication belongs to the class of drugs known as antispasmodics. A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE. In 2023, this provider wrote 99 Medicare prescriptions for Solifenacin Succinate, about 3.4 times the volume of the typical Indiana prescriber of this medication (29). Medicare paid an average of $88.37 per fill, versus $77.65 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 169.2 30-Day Fills standardized to 30-day supplies 5,003 Days of Medication total across all patients in 2023 | |||
| Cephalexin | 98 | $13.87 | ▲ More than typical |
About Cephalexin: This medication is used to treat a wide variety of bacterial infections. Show more ▾ This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. In 2023, this provider wrote 98 Medicare prescriptions for Cephalexin, about 3 times the volume of the typical Indiana prescriber of this medication (33). Medicare paid an average of $13.87 per fill, versus $8.94 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 204 30-Day Fills standardized to 30-day supplies 5,458 Days of Medication total across all patients in 2023 | |||
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 74 | $22.30▼ below IN avg | ▲ More than typical |
About Nitrofurantoin Mono-Macro: This medication is an antibiotic used to treat bladder infections (acute cystitis). Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. This medication should not be used in infants younger than 1 month old (see also Precautions section). This drug should not be used to treat infections outside the bladder (including kidney infections such as pyelonephritis or perinephric abscesses). In 2023, this provider wrote 74 Medicare prescriptions for Nitrofurantoin Mono-Macro, about 2.8 times the volume of the typical Indiana prescriber of this medication (26). Medicare paid an average of $22.30 per fill, versus $26.63 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 78 30-Day Fills standardized to 30-day supplies 767 Days of Medication total across all patients in 2023 | |||
| GemtesaVibegron | 73 | $649.34 | ▲ More than typical |
About Gemtesa: This medication is used to treat overactive bladder. Show more ▾ Overactive bladder is a problem with how your bladder stores urine that causes a sudden urge to urinate. The urge may be hard to control, and overactive bladder symptoms may include frequent urination, strong sudden urges to urinate, or involuntary loss of urine (incontinence). Vibegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder. In 2023, this provider wrote 73 Medicare prescriptions for Gemtesa, about 1.4 times the volume of the typical Indiana prescriber of this medication (52). Medicare paid an average of $649.34 per fill, versus $413.77 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 96 30-Day Fills standardized to 30-day supplies 2,832 Days of Medication total across all patients in 2023 | |||
| Ciprofloxacin Hcl | 44 | $9.42 | ▲ More than typical |
About Ciprofloxacin Hcl: This medication is used to treat eye infections. Show more ▾ Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A broad-spectrum antimicrobial carboxyfluoroquinoline. In 2023, this provider wrote 44 Medicare prescriptions for Ciprofloxacin Hcl, about 1.6 times the volume of the typical Indiana prescriber of this medication (28). Medicare paid an average of $9.42 per fill, versus $8.32 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 44 30-Day Fills standardized to 30-day supplies 371 Days of Medication total across all patients in 2023 | |||
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 38 | $6.78 | ▲ More than typical |
About Sulfamethoxazole-Trimethoprim: This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. Show more ▾ It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS. In 2023, this provider wrote 38 Medicare prescriptions for Sulfamethoxazole-Trimethoprim, about 1.4 times the volume of the typical Indiana prescriber of this medication (27). Medicare paid an average of $6.78 per fill, versus $6.14 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 46 30-Day Fills standardized to 30-day supplies 720 Days of Medication total across all patients in 2023 | |||
| Potassium Citrate ErPotassium Citrate | 38 | $138.87▼ below IN avg | ▲ More than typical |
About Potassium Citrate Er: This medication is used to make the urine less acidic. Show more ▾ This effect helps the kidneys get rid of uric acid, thereby helping to prevent gout and kidney stones. This medication can also prevent and treat certain metabolic problems (acidosis) caused by kidney disease. Citric acid and citrate salts (which contain potassium and sodium) belong to a class of drugs known as urinary alkalinizers. If you have a condition that requires you to limit your intake of potassium and sodium, your doctor may direct you to take a product that is lower in potassium and sodium. A powder that dissolves in water, which is administered orally, and is used as a diuretic, expectorant, systemic alkalizer, and electrolyte replenisher. In 2023, this provider wrote 38 Medicare prescriptions for Potassium Citrate Er, about 1.5 times the volume of the typical Indiana prescriber of this medication (25). Medicare paid an average of $138.87 per fill, versus $154.21 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 72.1 30-Day Fills standardized to 30-day supplies 1,965 Days of Medication total across all patients in 2023 | |||
| NitrofurantoinNitrofurantoin Macrocrystal | 31 | $49.12 | ≈ Typical |
About Nitrofurantoin: Nitrofurantoin is an antibiotic used to treat or prevent certain bladder infections. Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. This medication should not be used in infants younger than 1 month old (see also Precautions section). This drug should not be used to treat infections outside the bladder (including kidney infections such as pyelonephritis or perinephric abscesses). A urinary anti-infective agent effective against most gram-positive and gram-negative organisms. Although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression. In 2023, this provider wrote 31 Medicare prescriptions for Nitrofurantoin, about 1.2 times the volume of the typical Indiana prescriber of this medication (26). Medicare paid an average of $49.12 per fill, versus $44.37 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 45.2 30-Day Fills standardized to 30-day supplies 1,334 Days of Medication total across all patients in 2023 | |||
| Silodosin | 28 | $116.90▼ below IN avg | ≈ Typical |
About Silodosin: Silodosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Silodosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. In 2023, this provider wrote 28 Medicare prescriptions for Silodosin, about the same volume as the typical Indiana prescriber of this medication (25). Medicare paid an average of $116.90 per fill, versus $127.05 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 39 30-Day Fills standardized to 30-day supplies 1,132 Days of Medication total across all patients in 2023 | |||
| Alfuzosin Hcl ErAlfuzosin Hcl | 18 | $33.53 | ▼ Less than typical |
About Alfuzosin Hcl Er: Alfuzosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Alfuzosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. In 2023, this provider wrote 18 Medicare prescriptions for Alfuzosin Hcl Er, about a third of the volume of the typical Indiana prescriber of this medication (45). Medicare paid an average of $33.53 per fill, versus $31.94 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 26 30-Day Fills standardized to 30-day supplies 754 Days of Medication total across all patients in 2023 | |||
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $24.67▼ below IN avg | ▼ Less than typical |
About Clotrimazole-Betamethasone: This combination medication is used to treat a variety of inflamed fungal skin infections such as ringworm, athlete's foot, and jock itch. Show more ▾ This product contains 2 medications. Clotrimazole is an azole antifungal that works by preventing the growth of fungus. Betamethasone is a strong corticosteroid that works by reducing the swelling, redness, and itching that occurs in the skin infection. This medication is not recommended for children younger than 17 years or for diaper rash. In 2023, this provider wrote 15 Medicare prescriptions for Clotrimazole-Betamethasone, about 71% of the volume of the typical Indiana prescriber of this medication (21). Medicare paid an average of $24.67 per fill, versus $29.92 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 15 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
| Ampicillin Trihydrate | 12 | $17.38 | ≈ Typical |
About Ampicillin Trihydrate: Ampicillin is used to treat a wide variety of bacterial infections. Show more ▾ It is a penicillin-type antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. In 2023, this provider wrote 12 Medicare prescriptions for Ampicillin Trihydrate, about 75% of the volume of the typical Indiana prescriber of this medication (16). Medicare paid an average of $17.38 per fill, versus $17.05 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 159 Days of Medication total across all patients in 2023 | |||
| Desmopressin Acetate | 12 | $24.23▼ below IN avg | ▼ Less than typical |
About Desmopressin Acetate: Desmopressin is used to control the amount of urine your kidneys make. Show more ▾ Normally, the amount of urine you make is controlled by a certain substance in the body called vasopressin. In people who have water diabetes (diabetes insipidus) or certain kinds of head injury or brain surgery, the body does not make enough vasopressin. Desmopressin is a man-made form of vasopressin and is used to replace a low level of vasopressin. This medication helps to control increased thirst and too much urination due to these conditions, and helps prevent dehydration. Desmopressin is also used to control bleeding caused by surgery or injuries in people with certain bleeding problems (hemophilia A, type 1 von Willebrand's disease). It works by helping the body with normal blood clotting. A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR. In 2023, this provider wrote 12 Medicare prescriptions for Desmopressin Acetate, about 67% of the volume of the typical Indiana prescriber of this medication (18). Medicare paid an average of $24.23 per fill, versus $81.35 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 12 30-Day Fills standardized to 30-day supplies 313 Days of Medication total across all patients in 2023 | |||
| YuvafemEstradiol | 11 | $182.22 | ▼ Less than typical |
About Yuvafem: This medication is a female hormone (estrogen). Show more ▾ It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In 2023, this provider wrote 11 Medicare prescriptions for Yuvafem, about half the volume of the typical Indiana prescriber of this medication (20). Medicare paid an average of $182.22 per fill, versus $139.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25.8 30-Day Fills standardized to 30-day supplies 774 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for CHANDRA MARLIN NP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family prescribing approach at this Columbus, IN practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among IN prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
